CLINICAL_TRIALS
research
· 2025-12-22
Clinical Trial Update: Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)
Summary
A not-yet-recruiting clinical trial (MicrOzoGineTox) evaluating gut microbiome differences in gynecologic cancer patients with pelvic toxicity treated with ozon…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bernardino Clavo, MD, PhD | Conditions: Pelvic Toxicity, Radiation Toxicity | Status: NOT_YET_RECRUITING